Finding tomorrow’s
medical treatments

Clinical trials are a critical part of the drug discovery process. Every trial provides valuable information that can advance clinical research and knowledge. They help us make new and improved medical treatments possible.

We focus on enhancing patients' health and well-being, using new ways to collect and analyze data.

We are committed to sharing the results of our trials in respected journals and at medical conferences worldwide.

While conducting research, we prioritize the rights and safety of patients. We follow all laws and regulations to keep our research open and trustworthy.

Three people laughing

We are committed to diversity in clinical trials

It's crucial to include a mix of participants in clinical studies because treatments do not work the same for everyone. In the past, some groups were not well-represented. Now, researchers recognize that factors like gender, race, ethnicity, age, and economic background can affect how people respond to treatments.

Kyowa Kirin strives to include people from diverse backgrounds in their studies by raising awareness in diverse communities, providing flexible options to make participation more convenient, and sharing information with patient advocacy groups.

Clinical trial FAQs

A clinical trial is a research study that tests to see if a new potential treatment will be successful. Trials look to see how safe a new treatment is, including side effects and risks, and how effective it will be in improving the health of people with specific diseases, illnesses, or health problems.   

Successful clinical trials can lead to breakthroughs in treatment and help to ensure that proposed treatments are safe and effective.

A potential treatment must undergo 3 distinct stages or phases of study to be approved for public use. The phases start with testing for safety in a few people, then expand to see if the treatment is effective. Each phase has a different focus.

  • Phase 1: This is the initial stage of testing a new treatment in humans, primarily aimed at evaluating its safety, determining a safe dosage range, and identifying any side effects. These trials typically involve a small group of participants.
  • Phase 2: Researchers check if the treatment improves the specific condition by testing it on a larger group who have the disease or condition being studied. This phase helps provide more safety information.
  • Phase 3: Tests the treatment on a large group. It answers whether the treatment is safe and works better than standard options.
  • Phase 4: After the treatment is approved, this phase monitors its effectiveness and safety in a diverse group to see if any side effects show up later.

While every person’s motivation may be different, there are a few key considerations when deciding whether to take part in a clinical trial: 

  • Access to New Treatments 
  • Helping Others 
  • Advancing Science

Clinical trials follow a well-established protocol. The protocol outlines how the trial will be conducted, including its design, objectives, and methodology.  Know that clinical studies are closely monitored and may be stopped if it’s determined that the treatment is not effective or is causing more harm than benefit to participants. 

  1. How to participate in a clinical trial
    To join a clinical trial, you need to follow specific guidelines. A member of the trial team will explain the study and ask questions to see if it’s a good fit for you. If you qualify, you can start the enrolment process.
  2. How to find a clinical trial you may be interested In
    To find a clinical trial by Kyowa Kirin, you can visit one of the following websites based on where you live: -